scispace - formally typeset
G

Geoffrey C. Gurtner

Researcher at Stanford University

Publications -  478
Citations -  32002

Geoffrey C. Gurtner is an academic researcher from Stanford University. The author has contributed to research in topics: Wound healing & Medicine. The author has an hindex of 76, co-authored 423 publications receiving 25985 citations. Previous affiliations of Geoffrey C. Gurtner include Duke University & York University.

Papers
More filters
Journal ArticleDOI

QS44. Transdermal Deferoxamine Improves Excisional Wound Healing in Chronically Irradiated Murine Skin

TL;DR: In this article , the effects of transdermal deferoxamine (DFO) on excisional wound healing in chronically irradiated skin in a mouse model were investigated. And the results showed that DFO-treated mice grossly demonstrated faster wound closure rates than the vehicle and IR control groups.
Journal ArticleDOI

P39: Genetically Modified Microvascular Free Flaps Expressing IL-12 Result in Localized Tumor Regression without Systemic Toxicity

TL;DR: An ex vivo technique to transduce microvascular free flaps with a recombinant adenoviral vector which expresses the anti-tumor cytokine IL2 is developed, able to target treatment specifically to the required area without eliciting the known toxic effects associated with systemic administration of IL2.
Journal ArticleDOI

23. Endothelial Specific CXCL12 Regulates Neovascularization Through Fibroblast VEGF Signaling during Tissue Repair and Regeneration

TL;DR: In this paper, the role of extracellular calcium signaling through store-operated calcium channels, such as Orai1, on osteogenic differentiation of primary bone marrow-derived human mesenchymal stem cells (hMSCs), was examined.

P25. neurostitch: nanofabrication of a high resolution, biomimetic peripheral nerve interface

TL;DR: In the absence of adipose grafts, chondrocytes that were crushed exhibited significant less IL-13 secretion throughout the 48 hours while cartilages with adiposes grafts maintained and increased TGF-Beta secretion.
Journal ArticleDOI

MMP9 as a Potential Biomarker in 631 Human Implant-Induced Fibrotic Capsules A Systematic Analysis and Biomarker Study.

TL;DR: In this paper , a knowledge-based network generation and pathway association study was performed to identify putative novel biomarkers for capsular fibrosis, including MMP9, which is one of the most upregulated genes.